Clinical Trial Update: Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update reporting safety and pharmacokinetics data for the combination broadly neutralizing antibodies 3BNC117-LS-J and 10-1074-LS-J in healthy a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 10-1074-LS-J (10-1074-LS-J)
• 3BNC117-LS-J (3BNC117-LS-J)

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV-1-infection | Phase 1, Phase 2 | Status: COMPLETED